AbbVie Announces Launch Of PRODUODOPA In The EU – Quick Facts
(RTTNews) – AbbVie (ABBV) announced the launch of PRODUODOPA in the European Union for the treatment of advanced Parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia, and when available combinations of Parkinson’s medicinal products have not given sa